Table 1 Characteristics of Included Trials.
Study | Year | Study Design | Patients/Orbits (n) | Mean FU duration (range), months | Fracture Patterns | Primary or Secondary Reconstruction |
|---|---|---|---|---|---|---|
Bly19 | 2013 | HCT | 90/90 | 257 days (8–1209 days) | Assisted: Floor (18%), Medial Wall (7%), 2 Walls (38%), 3 or 4 Walls (38%) Control: Floor (20%), Medial Wall (4%), 2 Walls (33%), 3 or 4 Walls (42%) | Primary |
Cai20 | 2012 | PCS | 58/58 | 12 | Assisted: Floor (44%), Roof (8%), Medial wall (24%), Lateral wall (24%) Control: Floor (49%), Roof (7%), Medial wall (22%), Lateral wall (22%) | Primary |
Lauer21 | 2006 | PCS | 20/24 | (12–36) | ≥3 of the following involved: zygomatic, floor, medial wall, roof, naso-orbito- ethmoid complex, maxilla | Secondary |
Nkenke22 | 2011 | PCS | 20/20 | (3–12) | Floor | Secondary |
Scolozzi23 | 2010 | PCS | 20/20 | (6–13) | Assisted: Medial wall (0%), Floor (70%), Both (30%) Control: Medial wall (30%), Floor (60%), Both (10%) | Primary |
Guo24 | 2009 | RCS | 61/61 | 14.6 (8–22) | Floor | Primary |
